New study takes us a step closer to individualized treatment

New study by 64 renowned scientists standardizes on microarray protocols. Microarrays allow scientists to see how differences in gene expression are linked to specific diseases. Standardization brings us closer to doing routine lab tests with microarrays. This paves the way for prescribing individualized drugs, drugs made just for you.

The bottomline is that someone had to do this standardization. It requires huge funds and resources which an organization like NIH can provide and they did.

The study, conducted by the Toxicogenomics Research Consortium, which is funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, was initiated in 2001 to asses what causes variation in gene expression experiments within and between labs, as well as within and between microarray platforms.